当前位置:
X-MOL 学术
›
World J. Gastrointest. Surg.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Multidisciplinary management of acute mesenteric ischemia: Surgery and endovascular intervention.
World Journal of Gastrointestinal Surgery ( IF 1.8 ) Pub Date : 2021-9-14 , DOI: 10.4240/wjgs.v13.i8.806 Takashi Sakamoto 1 , Tadao Kubota 2 , Hiraku Funakoshi 3 , Alan Kawarai Lefor 4
World Journal of Gastrointestinal Surgery ( IF 1.8 ) Pub Date : 2021-9-14 , DOI: 10.4240/wjgs.v13.i8.806 Takashi Sakamoto 1 , Tadao Kubota 2 , Hiraku Funakoshi 3 , Alan Kawarai Lefor 4
Affiliation
Acute mesenteric ischemia (AMI) is a rare cause of the "acute abdomen", characterized by impaired blood flow to the intestine. The principle of treatment is restoration of perfusion to ischemic bowel and resection of any necrotic intestine. Surgery and endovascular intervention are two complementary approaches to mesenteric ischemia. Endovascular intervention is not an alternative to the surgical approach, but it has the potential to improve the prognosis of patients with AMI when judiciously combined with a surgical approach. Due to the need for emergent treatment of patients with acute mesenteric ischemia, the treatment strategy needs to be modified for each facility. This review aims to highlight cutting-edge studies and provide reasonable treatment strategies for patients with acute mesenteric ischemia based on available evidence.
中文翻译:
急性肠系膜缺血的多学科管理:手术和血管内干预。
急性肠系膜缺血 (AMI) 是“急腹症”的罕见原因,其特征是流向肠道的血流受损。治疗的原则是恢复缺血肠的灌注和切除任何坏死的肠。手术和血管内介入治疗是治疗肠系膜缺血的两种互补方法。血管内介入不是手术方法的替代方法,但当明智地与手术方法结合时,它有可能改善 AMI 患者的预后。由于急性肠系膜缺血患者需要紧急治疗,因此需要针对每个机构修改治疗策略。本综述旨在突出前沿研究,并根据现有证据为急性肠系膜缺血患者提供合理的治疗策略。
更新日期:2021-09-14
中文翻译:
![](https://scdn.x-mol.com/jcss/images/paperTranslation.png)
急性肠系膜缺血的多学科管理:手术和血管内干预。
急性肠系膜缺血 (AMI) 是“急腹症”的罕见原因,其特征是流向肠道的血流受损。治疗的原则是恢复缺血肠的灌注和切除任何坏死的肠。手术和血管内介入治疗是治疗肠系膜缺血的两种互补方法。血管内介入不是手术方法的替代方法,但当明智地与手术方法结合时,它有可能改善 AMI 患者的预后。由于急性肠系膜缺血患者需要紧急治疗,因此需要针对每个机构修改治疗策略。本综述旨在突出前沿研究,并根据现有证据为急性肠系膜缺血患者提供合理的治疗策略。